These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11166332)

  • 1. G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells.
    Dautzenberg FM; Hauger RL
    Neuropharmacology; 2001 Mar; 40(3):394-407. PubMed ID: 11166332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation.
    Dautzenberg FM; Braun S; Hauger RL
    Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R935-46. PubMed ID: 11247813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.
    Muller A; Lutz-Bucher B; Kienlen-Campard P; Koch B; Loeffler JP
    J Neurochem; 1998 Apr; 70(4):1431-40. PubMed ID: 9523559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
    Braas KM; May V
    J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
    Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
    J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide (PACAP) actions on alphaT3-1 gonadotrophs show desensitization.
    McArdle CA; Forrest-Owen W
    J Neuroendocrinol; 1997 Dec; 9(12):893-901. PubMed ID: 9468014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery.
    Hauger RL; Dautzenberg FM; Flaccus A; Liepold T; Spiess J
    J Neurochem; 1997 Jun; 68(6):2308-16. PubMed ID: 9166723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.
    Lelièvre V; Pineau N; Du J; Wen CH; Nguyen T; Janet T; Muller JM; Waschek JA
    J Biol Chem; 1998 Jul; 273(31):19685-90. PubMed ID: 9677397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional and post-transcriptional regulation of tyrosine hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways.
    Corbitt J; Hagerty T; Fernandez E; Morgan WW; Strong R
    Neuropeptides; 2002 Feb; 36(1):34-45. PubMed ID: 12147212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants.
    Dautzenberg FM; Mevenkamp G; Wille S; Hauger RL
    J Neuroendocrinol; 1999 Dec; 11(12):941-9. PubMed ID: 10583729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
    D'Agata V; Cavallaro S; Stivala F; Canonico PL
    Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N; Harada M; Hosoya M; Fujino M
    Eur J Biochem; 1994 Jul; 223(1):147-53. PubMed ID: 7913440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.